Latin American healthcare provider Auna has launched its initial public offering (IPO) on the New York Stock Exchange (NYSE), trading under the ticker AUNA.  

The company raised $360m in gross proceeds by issuing 30 million Class A shares at $12.00 per share. 

The offering is set to settle near 26 March 2024, subject to various customary closing conditions.  

Auna has also provided underwriters with a 30-day option to buy an additional 4.5 million Class A shares at the IPO price.  

Auna president and board executive chairman Suso Zamora said: “Auna’s listing on the NYSE today is a major milestone for our company and reaffirms our mission to transform healthcare in Spanish-speaking Latin America by providing the region’s rapidly growing population with access to highly integrated healthcare.  

“Our debut in the international equity markets is also the culmination of the hard work and dedication of the doctors, nurses, managers and many other colleagues who have helped create one of the region’s largest and most modern healthcare platforms.” 

The healthcare provider is now planning to allocate the $350m net proceeds from the offering to repurchase a 21.2% interest in Auna Salud SAC and for other corporate purposes.  

With a presence in Mexico, Peru, and Colombia, Auna focuses on preventing and managing high-complexity diseases that significantly impact healthcare costs. 

Established in 1989, the company aims to enhance healthcare accessibility in the underpenetrated Spanish-speaking markets of the Americas.  

As of 31 December 2023, Auna operated 31 healthcare facilities, with a total of 2,308 beds, and provided 1.3 million healthcare plans. 

For the full year 2023, Auna reported revenues of $1.05bn and adjusted earnings before interest, taxes, depreciation and amortisation of $223m, marking growths of 58% and 90%, respectively.